[[nid:hemophilia/xyntha/indication-safetyinfo.html]] [[nid:hemophilia/benefix/indication-safetyinfo-home.html]] [[nid:hemophilia/benefix/references.html]]

References:

  1. Xyntha® Solofuse® Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Prescribing Information, Wyeth Pharmaceuticals Inc.
  2. Center for Biologics Evaluation and Research, US Food and Drug Administration, US Department of Health and Human Services. CBER Approval Letter, Coagulation Factor IX (Recombinant), Genetics Institute, Inc. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm057039.htm. Published February 11, 1997. Accessed September 5, 2012.
  3. BeneFix® Coagulation Factor IX (Recombinant) Prescribing Information, Wyeth Pharmaceuticals Inc. 11.2011.
[[nid:hemophilia/includes/isi_floating.html]]